Overview
Yuko Ishihara practices in Tokyo, Japan. Ms. Ishihara is rated as an Experienced expert by MediFind in the treatment of Tuberculous Meningitis. Her top areas of expertise are Agranulocytosis, Graft Versus Host Disease (GvHD), Febrile Neutropenia, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Transplant.
Her clinical research consists of co-authoring 81 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Tuberculous Meningitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AgranulocytosisMs. Ishihara isAdvanced. Learn about Agranulocytosis.
- Bone Marrow TransplantMs. Ishihara isAdvanced. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)Ms. Ishihara isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Ishihara isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaMs. Ishihara isExperienced. Learn about Adult T-Cell Leukemia.
- Aplastic AnemiaMs. Ishihara isExperienced. Learn about Aplastic Anemia.
- AspergillosisMs. Ishihara isExperienced. Learn about Aspergillosis.
- B-Cell LymphomaMs. Ishihara isExperienced. Learn about B-Cell Lymphoma.
- Chronic Myelogenous Leukemia (CML)Ms. Ishihara isExperienced. Learn about Chronic Myelogenous Leukemia (CML).